CONSULTING AGREEMENTConsulting Agreement • May 9th, 2019 • CytomX Therapeutics, Inc. • Pharmaceutical preparations • California
Contract Type FiledMay 9th, 2019 Company Industry JurisdictionThis Consulting Agreement (the “Agreement”) is made and entered into by and between CytomX Therapeutics, Inc., a Delaware corporation, with an address at 151 Oyster Point Blvd, Suite 400, South San Francisco, CA 94080, (“Company”) and, Debanjan Ray, an individual (“Consultant”), effective as of May 15, 2019 (“Effective Date”).
CONSULTING AGREEMENTConsulting Agreement • February 27th, 2019 • CytomX Therapeutics, Inc. • Pharmaceutical preparations • California
Contract Type FiledFebruary 27th, 2019 Company Industry JurisdictionThis Consulting Agreement (the “Agreement”) is made and entered into by and between CytomX Therapeutics, Inc., a Delaware corporation, with an address at 151 Oyster Point Blvd, Suite 400, South San Francisco, CA 94080, (“Company”) and, Dr. Hoyoung Huh, M.D., Ph.D, an individual residing at * (“Consultant”), effective as of December 31, 2018 (“Effective Date”).